Federal Circuit Rules For Competitive Technologies In Patent Suit Vs. LabCorp

Law360, New York (June 8, 2004, 12:00 AM EDT) -- The U.S. Court of Appeals for the Federal Circuit has affirmed a lower court’s decision that Laboratory Corporation of America Holdings willfully contributed to and induced infringement of Competitive Technologies’s patent for a technology used in diagnoses of heart conditions.

In November 2002, Senior Judge Zita L. Weinshienk of the U.S. District Court for the District of Colorado ruled that LabCorp willfully contributed to and induced infringement of CTT's so-called homocysteine assay patent.

CTT, along with Metabolite Laboratories, sued LabCorp in May 1999. The complaint alleged,...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.